Nightingale Health Oyj Class B (7XE) Stock Statistics & Valuation Metrics

Nightingale Health Oyj Class B has a market cap or net worth of EUR 84.97M. The enterprise value is EUR 24.52M.

Market Cap

EUR 84.97M

Enterprise Value

EUR 24.52M

Nightingale Health Oyj Class B has 40,647,778 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

40,647,778

Owned by Insiders

―

Owned by Institutions

―

Nightingale Health Oyj Class B’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

Return on Equity (ROE)

―

Return on Assets (ROA)

―

Return on Invested Capital (ROIC)

―

Return on Capital Employed (ROCE)

―

Revenue Per Employee

―

Profits Per Employee

-62.81K

Employee Count

64

Asset Turnover

―

Inventory Turnover

―

In the last 12 months, Nightingale Health Oyj Class B had revenue of ― and earned -4.02M in profits. Earnings per share was ―.

Revenue

―

Gross Profit

1.63M

Operating Income

-3.78M

Pretax Income

―

Net Income

-4.02M

EBITDA

-3.55M

Earnings Per Share (EPS)

―

Beta

-0.01

52-Week Price Change

-38.90%

50-Day Moving Average

0.90

200-Day Moving Average

1.01

Relative Strength Index (RSI)

67.51

Average Volume (3m)

1,500

Nightingale Health Oyj Class B upcoming earnings date is Mar 09, 2027, Before Open (Not Confirmed).

Last Earnings Date

Sep 16, 2026

Next Earnings Date

Mar 09, 2027

Ex-Dividend Date

―

Nightingale Health Oyj Class B has ― in cash and marketable securities with EUR 5.84M in debt, giving a net cash position of ― billion.

Cash & Marketable Securities

―

Total Debt

EUR 5.84M

Net Cash

―

Net Cash Per Share

―

Tangible Book Value Per Share

―

The average price target for Nightingale Health Oyj Class B is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

17.21%

EPS Growth Forecast

-0.03%